Healthcare -
Biotechnology - NASDAQ - US
$ 40.88
-0.39 %
$ 15.7 B
Market Cap
-7.04
P/E
MRNA - STOCK-BASED COMPENSATION
Stock-based Compensation MRNA - Moderna, Inc.
305 M
LAST VALUE
46.56%
2 YEAR CAGR
33.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR